2004
Transaction will bring together cardiovascular expertise and technologies to benefit patients and physicians worldwide New Brunswick, N.J. and Indianapolis, Ind. - Johnson & Johnson (NYSE: JNJ),...
Company Reiterates Guidance for the Fourth Quarter 2004, Full-Year 2004 and 2005 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today provided a mid-quarter update reiterating financial...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
CAPTURE Will Advance Understanding of Carotid Stenting In High-Risk Patients at 150 U.S. Sites Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has begun...
Proposed Expanded Medicare Coverage for Implantable Defibrillators, SPIRIT FIRST Drug Eluting Stent Results and Carotid Stent System Approval Highlight Quarter Worldwide implantable defibrillator...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a fourth quarter dividend of $0.10 per share on outstanding common stock. This...
INDIANAPOLIS, IND. - Guidant Corporation (NYSE: GDT) will conduct a live webcast of its third quarter 2004 earnings conference call on Thursday, October 21, at 11:00 a.m. EDT. Guidant will issue a...
Endoscopic Vessel Harvesting Reduces Pain, Minimizes Scarring and Speeds Recovery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Farouc A. Jaffer, M.D., of Massachusetts General Hospital,...
Results Demonstrate the Benefit of An Everolimus Eluting Coronary Stent with Durable Polymer; Investor Briefing Scheduled for 8:00 a.m. ET Tomorrow Indianapolis, Ind., and Washington, D.C. -...
Lifesaving Benefits of Implantable Defibrillators Supported by Multiple Clinical Trials Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today applauds the proposed...
Goal of Study Is To Help Physicians Recognize Patients At Risk of Unexpected Heart Attack Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced plans to conduct...
Highly Deliverable New Stent Broadens Guidant''s Market-Leading Metallic Stent Portfolio Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and...
International Trial Will Study Unnecessary Pacing in Heart Failure Patients Indianapolis, Ind. And St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that it has completed...
Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company''s...
National Registry Will Now Focus on Patient Identification and Treatment Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:GDT) today announced that its ADVANCENTSM national...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today commended the Centers for Medicare & Medicaid Services (CMS) for its intent to expand coverage of carotid artery...
Federal Circuit Court of Appeals Returns the Case to Lower Court to Determine Infringement and Damages Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won its appeal...
New Carotid Stent System Offers Minimally Invasive Alternative to Open Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Collaboration Explores Advanced Applications for Gene Therapy to Benefit Heart Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced a collaboration...
Company to Reiterate Third Quarter and Full-Year Guidance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call today, Thursday, , at...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its regularly scheduled mid-quarter conference call to provide an update on the...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...